Consideration of cytokines as therapeutics agents or targets

被引:16
作者
Xing, Z
Wang, J
机构
[1] McMaster Univ, Hlth Sci Ctr, Dept Pathol & Mol Med, Hamilton, ON L8N 3Z5, Canada
[2] McMaster Univ, Ctr Gene Therapeut, Div Infect Dis, Hamilton, ON L8N 3Z5, Canada
关键词
D O I
10.2174/1381612003400623
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
There has been an explosion of our knowledge in cytokine biology in the last decade. Such knowledge is being quickly translated into the identification of etiologies and improved prophylaxis and therapy of disease. While cytokines have the potential to be used as therapeutics or immune adjuvants for certain diseases, they may also be culprits as therapeutic targets in other diseases. This review article serves as an introduction to the other five articles in this thematic issue each of which has a specific focus on the frontier of cytokine therapeutic biology. This review contains sections dealing with general cytokine properties, cytokine classifications, human conditions caused by cytokine under-expression and overexpression, Th1 and Th2 paradigm, cytokine therapy for acute/chronic inflammatory conditions, cytokine therapy for infectious diseases, and cytokine therapy for cancer.
引用
收藏
页码:599 / 611
页数:13
相关论文
共 122 条
  • [1] Ahlers JD, 1997, J IMMUNOL, V158, P3947
  • [2] Mendelian susceptibility to mycobacterial infection in man
    Altare, F
    Jouanguy, E
    Lamhamedi, S
    Döffinger, R
    Fischer, A
    Casanova, JL
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1998, 10 (04) : 413 - 417
  • [3] Inherited interleukin 12 deficiency in a child with bacille Calmette-Guerin and Salmonella enteritidis disseminated infection
    Altare, F
    Lammas, D
    Revy, P
    Jouanguy, E
    Döffinger, R
    Lamhamedi, S
    Drysdale, P
    Scheel-Toellner, D
    Girdlestone, J
    Darbyshire, P
    Wadhwa, M
    Dockrell, H
    Salmon, M
    Fischer, A
    Durandy, A
    Casanova, JL
    Kumararatne, DS
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (12) : 2035 - 2040
  • [4] Gene therapy for asthma: inspired research or unnecessary effort?
    Alton, EWFW
    Griesenbach, U
    Geddes, DM
    [J]. GENE THERAPY, 1999, 6 (02) : 155 - 156
  • [5] TUMOR-NECROSIS-FACTOR-ALPHA PLUS INTERLEUKIN-1-BETA TREATMENT PROTECTS GRANULOCYTOPENIC MICE FROM PSEUDOMONAS-AERUGINOSA LUNG INFECTION - ROLE OF AN UNUSUAL INFLAMMATORY RESPONSE
    AMURA, CR
    FONTAN, PA
    SANJUAN, N
    NOCIARI, MM
    BUZZOLA, FR
    SORDELLI, DO
    [J]. APMIS, 1995, 103 (06) : 447 - 459
  • [6] Inhibitory cytokines in asthma
    Barnes, PJ
    Lim, S
    [J]. MOLECULAR MEDICINE TODAY, 1998, 4 (10): : 452 - 458
  • [7] Effect of topical application of nerve-growth factor on pressure ulcers
    Bernabei, R
    Landi, F
    Bonini, S
    Onder, G
    Lambiase, A
    Pola, R
    Aloe, L
    [J]. LANCET, 1999, 354 (9175) : 307 - 307
  • [9] Cytokine production after influenza vaccination in a healthy elderly population
    Bernstein, ED
    Gardner, EM
    Abrutyn, E
    Gross, P
    Murasko, DM
    [J]. VACCINE, 1998, 16 (18) : 1722 - 1731
  • [10] Characterization of the rat, mouse, and human genes of growth/differentiation factor-15/macrophage inhibiting cytokine-1 (GDF-15/MIC-1)
    Böttner, M
    Laaff, M
    Schechinger, B
    Rappold, G
    Unsicker, K
    Suter-Crazzolara, C
    [J]. GENE, 1999, 237 (01) : 105 - 111